Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder

British Journal of Psychiatry

Volumn 199, Issue 3, 2011, Pages 211-218

  Butters, Meryl A ^a   Bhalla, Rishi K ^b   Andreescu, Carmen ^a   Wetherell, Julie Loebach ^c   Mantella, Rose ^d   Begley, Amy E ^a   Lenze, Eric J ^e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ABBOTT LABORATORIES   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPTH PERCEPTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EPISODIC MEMORY; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; PROBLEM SOLVING; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; WORKING MEMORY;

ADULT; AGE FACTORS; AGED; ANXIETY DISORDERS; ATTENTION; CITALOPRAM; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MENTAL PROCESSES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 80052396966     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.090217     Document Type: Article

References (44)

1. Beekman A.T., Bremmer M.A., Deeg D.J., Van Balkom A.J., Smit J.H., De Beurs E., et al. Anxiety disorders in later life: A report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998; 13: 717-726 (Pubitemid 28491262)
2. Bryant C., Jackson H., Ames D. The prevalence of anxiety in older adults: Methodological issues and a review of the literature. J Affect Disord 2008; 109: 233-250
3. Gum A.M., King-Kallimanis B., Kohn R. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry 2009; 17: 769-781
4. Diefenbach G.J., Stanley M.A., Beck J.G. Worry content reported by older adults with and without generalized anxiety disorder. Aging Ment Health 2001; 5: 269-274 (Pubitemid 32845621)
5. Chou K.L. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 2009; 17: 455-464
6. Le Roux H., Gatz M., Wetherell J.L. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 2005; 13: 23-30. (Pubitemid 41031112)
7. Lenze E.J., Rollman B.L., Shear M.K., Dew M.A., Pollock B.G., Ciliberti C., et al. Escitalopram for older adults with generalized anxiety disorder: A randomized controlled trial. JAMA 2009; 301: 295-303.
8. Stanley M.A., Beck J.G., Novy D.M., Averill P.M., Swann A.C., Diefenbach G.J., et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol 2003; 71: 309-319 (Pubitemid 36323935)
9. Porensky E.K., Dew M.A., Karp J.F., Skidmore E., Rollman B.L., Shear M.K., et al. The burden of late-life generalized anxiety disorder: Effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry 2009; 17: 473-482
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
11. Lenze E.J., Wetherell J.L. Bringing the bedside to the bench, and then to the community: A prospectus for intervention research in late-life anxiety disorders. Int J Geriatr Psychiatry 2009; 24: 1-14.
12. Mantella R.C., Butters M.A., Amico J.A., Mazumdar S., Rollman B.L., Begley A.E., et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 2008; 33: 773-781
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Nonpatient Edition. Biometrics Research Department, New York State Psychiatric Institute, 1996.
14. Folstein M., Folstein S., McHugh P. 'Mini-Mental State', a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
15. Randolph C. The Repeatable Battery for the Assessment of Neuropsychological Status. Psychological Corporation, 1998.
16. Delis D., Kaplan E., Kramer J. Delis-Kaplan Executive Function Scale. Psychological Corporation, 2001.
17. Trennery M., Crosson B., DeBoe J., Leber W. Stroop Neuropsychological Screening Test Manual. Psychological Assessment Resources, 1989.
18. Wechsler D. WAIS-III Administration and Scoring Manual. Psychological Corporation, 1997.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
20. Dombrovski A.Y., Blakesley-Ball R.E., Mulsant B.H., Mazumdar S., Houck P.R., Szanto K., et al. Speed of improvement in sleep disturbance and anxiety compared with core mood symptoms during acute treatment of depression in old age. Am J Geriatr Psychiatry 2006; 14: 550-554 (Pubitemid 43849534)
21. Jette A.M., Haley S.M., Coster W.J., Kooyoomjian J.T., Levenson S., Heeren T., et al. Late life function and disability instrument: I. Development and evaluation of the disability component. J Gerontol A Biol Sci Med Sci 2002; 57: M209-M216 (Pubitemid 34263297)
22. World Health Organization. The World Health Report: Reducing Risks, Promoting Healthy Life. WHO, 2002.
23. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, 1976.
24. Meyer T.J., Miller M.L., Metzger R.L., Borkovec T.D. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28: 487-495
25. Miller M.D., Paradis C.F., Houck P.R., Mazumdar S., Stack J.A., Rifai A.H., et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-248
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 10.
27. Airaksinen E., Larsson M., Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: Evidence of episodic memory dysfunction. J Psychiatr Res 2005; 39: 207-214 (Pubitemid 39602645)
28. Mantella R.C., Butters M.A., Dew M.A., Mulsant B.H., Begley A.E., Tracey B., et al. Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry 2007; 15: 673-679
29. Caudle D.D., Senior A.C., Wetherell J.L., Rhoades H.M., Beck J.G., Kunik M.E., et al. Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry 2007; 15: 680-689
30. Beaudreau S.A., O'Hara R. The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. Psychol Aging 2009; 24: 507-512
31. Wetherell J.L., Le Roux H., Gatz M. DSM-IV criteria for generalized anxiety disorder in older adults: Distinguishing the worried from the well. Psychol Aging 2003; 18: 622-627 (Pubitemid 37152079)
32. Cohen D., Eisdorfer C., Vitaliano P.P., Bloom V. The relationship of age, anxiety, and serum immunoglobulins with crystallized and fluid intelligence. Biol Psychiatry 1980; 15: 699-709. (Pubitemid 10004881)
33. Wetherell J.L., Reynolds C.A., Gatz M., Pedersen N.L. Anxiety, cognitive performance, and cognitive decline in normal aging. J Gerontol B Psychol Sci Soc Sci 2002; 57: P246-255
34. Bierman E.J., Comijs H.C., Jonker C., Beekman A.T. Effects of anxiety versus depression on cognition in later life. Am J Geriatr Psychiatry 2005; 13: 686-693 (Pubitemid 41197239)
35. Deptula D., Singh R., Pomara N. Aging, emotional states, and memory. Am J Psychiatry 1993; 150: 429-434 (Pubitemid 23072468)
36. Paterniti S., Dufouil C., Bisserbe J.C., Alperovitch A. Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol Med 1999; 29: 421-428 (Pubitemid 29129326)
37. Hogan M.J. Divided attention in older but not younger adults is impaired by anxiety. Exp Aging Res 2003; 29: 111-136 (Pubitemid 36522979)
38. Biringer E., Mykletun A., Dahl A.A., Smith A.D., Engedal K., Nygaard H.A., et al. The association between depression, anxiety, and cognitive function in the elderly general population-the Hordaland Health Study. Int J Geriatr Psychiatry 2005; 20: 989-997 (Pubitemid 43055112)
39. Lindesay J., Briggs K., Murphy E. The Guy's/Age Concern survey. Prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 1989; 155: 317-329 (Pubitemid 19237003)
40. Price R.B., Mohlman J. Inhibitory control and symptom severity in late life generalized anxiety disorder. Behav Res Ther 2007; 45: 2628-2639 (Pubitemid 47513641)
41. Borkovec T.D., Inz J. The nature of worry in generalized anxiety disorder: A predominance of thought acitivity. Behav Res Ther 1990; 28: 153-158 (Pubitemid 20145832)
42. Ingram R.E., Kendall P.C., Smith T.W., Donnell C., Ronan K. Cognitive specificity in emotional distress. J Pers Soc Psychol 1987; 53: 734-742
43. Whalen P.J., Bush G., McNally R.J., Wilhelm S., McInerney S.C., Jenike M.A., et al. The emotional counting Stroop paradigm: A functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 1998; 44: 1219-1228 (Pubitemid 29015861)
44. Andreescu C., Butters M., Lenze E.J., Venkatraman V.K., Nable M., Reynolds 3rd C.F., et al. fMRI activation in late-life anxious depression: A potential biomarker. Int J Geriatr Psychiatry 2009; 24: 820-828